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Background: The purpose of this paper is to describe the data collection efforts and validation of PhenX measures
in the Personalized Medicine Research Project (PMRP) cohort.
Methods: Thirty-six measures were chosen from the PhenX Toolkit within the following domains: demographics;
anthropometrics; alcohol, tobacco and other substances; cardiovascular; environmental exposures; cancer;
psychiatric; neurology; and physical activity and physical fitness. Eligibility criteria for the current study included:
living PMRP subjects with known addresses who consented to future contact and were not currently living in a
nursing home, available GWAS data from eMERGE I for subjects where age-related cataract, HDL, dementia and
resistant hypertension were the primary phenotypes, thus biasing the sample to the older PMRP participants. The
questionnaires were mailed twice. Data from the PhenX measures were compared with information from PMRP
questionnaires and data from Marshfield Clinic electronic medical records.
Results: Completed PhenX questionnaires were returned by 2271 subjects for a final response rate of 70%. The
mean age reported on the PhenX questionnaire (73.1 years) was greater than the PMRP questionnaire (64.8 years)
because the data were collected at different time points. The mean self-reported weight, and subsequently
calculated BMI, were less on the PhenX survey than the measured values at the time of enrollment into PMRP
(PhenX means 173.5 pounds and BMI 28.2 kg/m2 versus PMRP 182.9 pounds and BMI 29.6 kg/m2). There was 95.3%
agreement between the two questionnaires about having ever smoked at least 100 cigarettes. 139 (6.2%) of
subjects indicated on the PhenX questionnaire that they had been told they had a stroke. Of them, only 15 (10.8%)
had no electronic indication of a prior stroke or TIA. All of the age-and gender-specific 95% confidence limits
around point estimates for major depressive episodes overlap and show that 31% of women aged 50–64 reported
symptoms associated with a major depressive episode.
Conclusions: The approach employed resulted in a high response rate and valuable data for future gene/
environment analyses. These results and high response rate highlight the utility of the PhenX Toolkit to collect valid
phenotypic data that can be shared across groups to facilitate gene/environment studies.* Correspondence: cmccarty@eirh.org
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The National Human Genome Research Institute funded
the development of consensus measures for Phenotypes
and eXposures (PhenX) [1,2]. The goal of PhenX was to
develop 15 measures for 21 different phenotypic domains.
Data collection worksheets are available through the
PhenX Toolkit (www.phenxtoolkit.org), with the hope that
broad acceptance and use of the PhenX measures will
allow for cross-study comparisons and improve the statis-
tical power for gene/environment analyses in the context
of genome-wide association studies (GWAS). PhenX mea-
sures were selected by working groups of domain experts
using a consensus process that included input from the
scientific community.
The eMERGE network (www.gwas.net), also funded by
the National Human Genome Research Institute, is a
national consortium formed to develop, disseminate, and
apply approaches to research that combine DNA biorepo-
sitories with electronic medical record (EMR) systems
for large-scale, high-throughput genetic research [3].
The Marshfield Clinic Personalized Medicine Research
Project (PMRP) [4] was one of the five initial eMERGE
sites, with cataract, HDL and diabetic retinopathy as the
primary phenotypic outcomes.
An administrative supplement funded by NHGRI to
the eMERGE grant allowed PMRP investigators to col-
lect PhenX measures for subjects with available GWAS
data from eMERGE. The PMRP team was one of seven
sites to makeup the PhenX RISING network that was
funded through administrative supplements to incorp-
orate PhenX measures into existing population-based
genomic studies (https://www.phenxtoolkit.org/index.php?
pageLink=phenxrising). In total, the seven groups incorpo-
rated 76 PhenX measures, representing a quarter of the
295 measures present in the Toolkit as of July 2011. The
measures encompass demographics, psychosocial risk fac-
tors, psychiatric assessments, and a variety of exposures.
Each group is adding between 4 and 37 measures with five
groups, including PMRP, adding more than 20 measures.
In all, 55 of these 81 measures are shared by two or more
groups providing common ground for future cross-study
analysis.
The purpose of this paper is to describe the data col-
lection efforts and validation of the PhenX measures in
the PMRP cohort.
Methods
The Marshfield Clinic Personalized Medicine Research Pro-
ject (PMRP) is a population-based biorepository linked to
the comprehensive electronic medical record of Marshfield
Clinic, details of which have been published previously [4].
Self-administered questionnaire data are available for the
cohort to facilitate gene/environment analyses, including
the detailed Dietary History Questionnaire [5].As part of the initial written informed consent to partici-
pate in PMRP, subjects were given the option to opt out of
future contact. Less than 1% of subjects elected this op-
tion. Eligibility criteria for the current study included:
living PMRP subjects with known addresses who con-
sented to future contact and were not currently living in
a nursing home. In addition, subjects were required to
have available GWAS data from eMERGE I, where age-
related cataract, HDL, dementia and resistant hyperten-
sion were the primary phenotypes [6], thus biasing the
sample to the older PMRP participants.
The current study was reviewed and approved by the
institutional review boards at Marshfield Clinic and
Essentia Institute of Rural Health. The PhenX Toolkit
(www.phenxtoolkit.org) was accessed to develop a self-
administered questionnaire to include the 36 items
listed in Table 1. Also listed in Table 1 are all data ele-
ments available for comparison with PMRP. Some of the
PhenX measures were included because of the potential
for gene/environment associations with age related cata-
ract (smoking, alcohol, ultraviolet light exposure), some
were included because data were available for validation
by comparison with prior PMRP questionnaire data and
medical history information (demographics, physical activ-
ity, family history of heart attack, history of stroke) and
the rest were included because of the potential for future
research and cross-site collaborations (hypomania/mania
symptoms, hand dominance) within the PhenX RISING
network funded through administrative supplements to
collect PhenX measures. The time to complete the ques-
tionnaire ranged from 20 to 40 minutes in pre-testing,
depending on how many questions were logical skips.
The 32-page self-administered questionnaire was mailed
to all eligible subjects with a cover letter and return
address envelope. A second mailing was employed to
increase the response rate. Subjects were offered $10 for
their time to complete the questionnaire. The mailings oc-
curred at the end of 2011 and beginning months of 2012.
The majority of PMRP participants were enrolled between
September 2002 and April 2004 so there is a considerable
time lag between completion of questionnaires.
PhenX survey data were entered and merged with prior
PMRP questionnaire information and data about prior
stroke from clinical diagnoses in the Marshfield Clinic
electronic medical record. Analyses in this report include
standard descriptive statistics and approximate confidence
limits. For validation purposes, the clinical diagnoses and
measurements from electronic medical record were con-
sidered to be the gold standard when it was used for com-
parison. The signed-ranks test was used to compare
PhenX self-reported weight and BMI with measurements
at PMRP enrollment, simple kappa statistics and 95% CL
were calculated for nominal categories and Fleiss-Cohen
weighted kappas and 95% CL for ordinal classifications as
Table 1 PhenX Toolkit measures employed in the current study and availability/comparability of PMRP data for
validation
PhenX ID PhenX measure name Available PMRP data source
for comparison
Comparability of measures (N/A for not applicable where there are
no data for comparison)
010101 Current age EMR Not identical but expect congruence because construct is same
010201 Birthplace No data N/A
010301 Birthplace of parents No data N/A
010401 Birthplace of grandparents No data N/A
010501 Ethnicity Enrollment questionnaire
(US Census question)
Fewer forced options were available on the PMRP questionnaire then the
PhenX questionnaire based on expected responses prior to the “other/
please specify” option. Construct is the same.
010601 Race Enrollment questionnaire
(US Census question)
Fewer forced options were available on the PMRP questionnaire then the
PhenX questionnaire based on expected responses prior to the “other/
please specify” option. Construct is the same.
010701 Gender EMR Not identical but expect congruence because construct is same
010801 Current address EMR Not identical but expect congruence because construct is same
010901 Current marital status No data N/A
011001 Current educational
attainment
Questionnaire for subset post
enrollment
Not identical but expect congruence because construct is same, fewer
forced categories for lower levels of education in PMRP questionnaire
based on expected responses
011301 Current employment status Enrollment questionnaire
(US Census question)
Similar construct, but not identical questions. PhenX includes 8 choices
for current working status. PMRP questionnaire asked about being
employed in the previous 5 years (yes/no)
011401 Household roster –
relationships
No data N/A
011501 Health insurance coverage EMR Not identical but expect congruence because construct is same
020602 Hand dominance (12 years
and older)
No data N/A
020704 Self-reported height Measured at enrollment, EMR Same construct, but expect some over-reporting based on literature
021502 Self-reported weight Measured at enrollment, EMR Same construct, but expect some under-reporting based on literature
030101 Alcohol – lifetime use No data N/A
030201 Alcohol – age of first use No data N/A
030301 Alcohol – 30-day frequency
and quantity
Enrollment questionnaire Same construct, but PhenX did not have forced category responses.
PhenX had open-ended number of days and number of drinks per day.
PMRP had forced categories of response (<1, 1–2, 3–4, 5–7 days per week
and 1, 2, 3–4, 50 or more drinks per day)
030401 Alcohol – maximum drinks
in 24 hours
No data N/A
030501 Alcohol – lifetime abuse and
dependence
No data N/A
030602 Tobacco – smoking status
(adult protocol)
Enrollment questionnaire Identical questions
030702 Tobacco – age of initiation
of use (adult protocol)
No data N/A
030802 Tobacco – 30-day quantity
and frequency (adult
protocol)
Enrollment questionnaire Identical questions
030902 Tobacco – age of offset of
use (adult protocol)
No data N/A
031001 Tobacco – nicotine
dependence
No data N/A
040101 Family history of heart
attack
Family history of heart or
stroke from enrollment
questionnaire
Similar construct but definition of relatives is different and two health
outcomes were included in the PMRP questionnaire
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Table 2 Demographic and anthropometric data as reported on PhenX survey and at PMRP enrollment
PhenX gender
PMRP Female Male Unknown Combined
Gender N (%) N (%) N (%) N (%)
Female 1344 (59.2) 0 (0) 17 (0.7) 1361 (59.9)
Male 0 (0) 898 (39.5) 12 (0.5) 910 (40.1)
Combined 1344 (59.2) 898 (39.5) 29 (1.3) 2271 (100.0)
Kappa = 1.0 (95% CL=1.0, 1.0)
PhenX Race
PMRP race White only White+Other Other only Unknown Combined
N (%) N (%) N (%) N (%) N (%)
White Only 2177 (95.9) 1 (0.0) 3 (0.1) 67 (3.0) 2248 (99.0)
White+Other 8 (0.4) 4 (0.2) 2 (0.1) 0 (0) 6 (0.3)
Other Only 2 (0.1) 0 (00 4 (0.2) 0 (0) 3 (0.1)
Unknown 2 (0.1) 0 (0) 1 (0.0) 0 (0) 3 (0.1)
Combined 2189 (96.4) 5 (0.2) 10 (0.4) 67 (3.0) 2271 (100.0)
Kappa = 0.605 (95% CL=0.387, 0.823)
PhenX ethnicity
PMRP ethnicity Hispanic/Latino Not hispanic Unknown Combined
N (%) N (%) N (%) N (%)
Hispanic/Latino 4 (0.2) 1 (0.0) 0 (0) 5 (0.2)
Not Hispanic 8 (0.4) 2118 (93.3) 140 (6.2) 2266 (99.8)
Combined 12 (0.5) 2119 (93.3) 140 (6.2) 2271 (100.0)
Kappa = 0.469 (95% CL=0.175, 0.763)
PhenX survey PMRP questionnaire
N Mean S.D. Min. Max. N Mean S.D. Min. Max.
Age (years) 2271 7301 10.1 54. 101.7 2271 64.8 10.2 45.7 93.2
Weight (lbs) 2172 173.5 39.5 58.0 399.0 2172 182.9 39.3 76.0 350.0
Height (in) 2146 65.8 4.1 38.0 105.0 2146 65.8 3.7 48.0 77.0
BMI (kg/m2) 2109 28.2 5.8 10.3 75.4 2109 29.6 5.6 17.4 61.2
Agreement noted in bold.
Table 1 PhenX Toolkit measures employed in the current study and availability/comparability of PMRP data for
validation (Continued)






060801 Sibship/birth order No data N/A
061301 Ultraviolet light exposure No data N/A




120502 Depression – adult No data N/A
130301 History of stroke – ischemic
infarction and hemorrhage
EMR Similar construct but difficult to determine if people completing PhenX
questionnaire understand medical terms
150901 Total physical activity
screener
No comparable data N/A
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significant.
Results
Questionnaires were mailed to 3344 PMRP participants
with GWAS data. The denominator decreased to 3246
after participants were removed for eligibility reasons
(no known address, current nursing home residence,
deceased). Completed questionnaires were returned by
2271 subjects for a final response rate of 70%. Upon
comparing age and gender responses with Marshfield
Clinic EMR data, it was determined that two of the
respondents were the spouses of intended respondents
who had participated in the PMRP biobank but for
whom GWAS data were not available. Fifty-nine percent
of the respondents were female, reflecting a similar
response rate by gender (Table 2). The vast majority of
the study population reported being White (96.2%) and
of non-Hispanic (93.3%) ethnicity. The gender and race/
ethnicity of the respondents to the PhenX survey is
nearly identical to the original PMRP cohort, which is
similar to the general population of central Wisconsin,
other than an under-representation from men who were
less likely to participate initially in the PMRP biobank [4].
There was good agreement between the PhenX Toolkit
questions and the PMRP questionnaire on demographics.
The mean age at completion of the PhenX questionnaire
(73.1 years) was greater than the PMRP age at enrollment
from the EMR (64.8 years) because the data were collected
at different time points. The mean self-reported weight,
and subsequently calculated BMI, were significantly lessTable 3 Comparison of self-reported cigarette smoking betwe
PMRP
Smoked at least 100 cigarettes in entire life
No Yes
N (%) N (%
No 1151 (52.1) 16 (0.7
Yes 88 (4.0) 953 (53
Combined 1239 (56.1) 969 (43
Kappa = 0.905 (95% CL=0.887, 0.923)
Frequency of current smoking PMRP enrollment and PhenX follow-up
Every day Some d
N (%) N (%
Every day 60 (2.7) 12 (0.5
Some days 8 (0.4) 10 (0.
Not at all 13 (0.6) 9 (0.4
Combined 81 (3.7) 31 (1.4
Kappa = 0.673 (0.604, 0.741)
The numbers are the actual counts (and percent) of people responding “yes” or “no
cigarettes in their lifetime and whether they were currently smoking. Agreement (non the PhenX survey than the measured values at the time
of enrollment into PMRP (PhenX means 173.5 pounds
and BMI 28.2 versus PMRP 182.9 pounds and BMI 29.6,
each p < 0.001).
The smoking and alcohol questions are far more de-
tailed in the PhenX measures than the PMRP question-
naire. Table 3 present a comparison of responses to
identical smoking questions from the two sources,
queried on average eight years apart. There was 95.3%
agreement between the two questionnaires about having
ever smoked at least 100 cigarettes. The agreement be-
tween the two questionnaires for frequency of current
smoking was also 95.3%. Kappa statistics reflect the lower
agreement for current smoking than ever smoked (0.673
versus 0.905). The agreement for self-reported alcohol
intake was not as strong as for smoking and lower for
usual drinks per day in comparison with drinking in the
past 30 days (69.6% agreement for drinking in the past
30 days, Table 4, kappa = 0.666; and 73.9% for usual
number of drinks per day, Table 4, kappa = 0.507). This
makes sense because the referent 30-day period for
drinking was different.
Table 5 summarizes the comparison of PhenX mea-
sures with PMRP questionnaire and Marshfield Clinic
medical record data. The PhenX questionnaire included
a question about whether the respondent had ever been
told by a physician that they had a stroke, as well as a
series of questions about symptoms associated with
stroke. The PhenX responses were compared with diag-
nosis codes for stroke and transient ischemic attack







ays Not at all Combined
) N (%) N (%)
) 39 (1.8) 111 (5.0)
5) 23 (1.0) 41 (1.9)
) 2027 (92.1) 2049 (100.0)
) 2089 (94.9) 2201 (100.0)
” on the two questionnaires about whether they had ever smoked 100
o/no or yes/yes) is noted in bold.
Table 4 Comparison of self-reported alcohol intake between PMRP and PhenX
PhenX
<1 1-2 3-4 5-7 Combined
PMRP N (%) N (%) N (%) N (%) N (%)
Number of days in the past 30 days that respondent drank one or more drinks
<1 1204 (54.8) 89 (4.0) 22 (1.0) 9 (0.4) 1324 (60.2)
1-2 224 (10.2) 141 (6.4) 41 (1.9) 16 (0.7) 422 (19.2)
3-4 63 (2.9) 66 (3.0) 52 (2.4) 35 (1.6) 216 (9.8)
5-7 42 (1.9) 28 (1.3) 33 (1.5) 133 (6.1) 236 (10.7)
Combined 1533 (69.7) 324 (14.7) 148 (6.7) 193 (8.8) 2198 (100.0)
Kappa = 0.666 (95% CL=0.627, 0.704)
<1 1-2 3-4 5 or more Combined
PMRP N (%) N (%) N (%) N (%) N (%)
Usual number of drinks per day
<1 502 (24.9) 96 (4.8) 7 (0.3) 6 (0.3) 611 (30.4)
1-2 231 (11.5) 921 (45.8) 47 (2.3) 21 (1.0) 1220 (60.6)
3-4 15 (0.7) 67 (3.3) 51 (2.5) 11 (0.5) 144 (7.2)
5 or more 6 (0.3) 8 (0.4) 10 (0.5) 14 (0.7) 38 (1.9)
Combined 754 (37.4) 1092 (54.2) 115 (5.7) 52 (2.6) 2013 (100.0)
Kappa = 0.507 (95% CL=0.445, 0.5688)
The numbers are the actual counts (and percent) of people reporting on the two questionnaires the number of days that they had an alcoholic drink in the
previous 30 days how drinks they had on a typical days in the previous 30 days. Agreement is noted in bold.
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naire that they had been told they had a stroke. Of them,
only 15 (10.8%) had no electronic indication of a prior
stroke or TIA. The agreement for no report of physician-
reported stroke on the PhenX questionnaire with no
stroke or TIA codes appearing in the Marshfield Clinic
EMR was 99.2%. The negative predictive value of self-
reported physician-diagnosed stroke (1875/1912, 98.1%
when no TIA code was found) was found to be higher
than the positive predictive value (92/113, 81.4% when
TIA code was present in the EMR).
Table 6 includes data to compare self-reported family
history of myocardial infarction between PhenX and
PMRP. The simple kappa statistic for the agreement was
0.352 (95% CL = 0.317, 0.386). In the PMRP enrollmentTable 5 Comparison of stroke history as reported on PhenX s
PhenX Physician-r
No
TIA code? Stroke codes? ———————————
N (row %)
No None 1875 (99.2)
1 only 23 (95.8)
2 or more 14 (58.3)
Yes None 155 (88.1)
1 only 14 (63.6)
2 or more 30 (26.3)questionnaire, subjects were asked if they had two or
more first degree relatives, including themselves, who
had ever had heart attack or angina. 589 of the subjects
in the current study reported a family history of heart
attack or angina on the PMRP questionnaire. 1108 of
subjects reported in the PhenX questionnaire that at
least one of their first degree relatives had a myocardial
infarction. It is difficult to compare the two responses
because the questions were asked differently, included
different people (self in the PMRP questionnaire), and
there was a time gap of an average eight years between
administration of the two questionnaires.
Table 7 summarizes age- and sex-specific prevalence
of major depressive disorder from the PhenX measure




N (row) Kappa statistic (95% CL)
15 (0.8)
1 (4.2)
10 (41.7) 0.285 (0.148, 0.422)
21 (11.9)
8 (36.4)
84 (73.7) 0.568 (0.476, 0.660)
Table 6 Family history* of heart attack as reported on
PhenX survey and of heart attack/angina as reported in
PMRP
PhenX family history of MI? PMRP family history of MI/Angina
Yes No Yes No
N % N % N % N %
1108 52.8 991 47.2 589 28.1 1510 71.9
Kappa=0.352 (95% CL=0.317, 0.386)
*Family history of MI or angina in first degree relatives.
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of the stratum-specific 95% confidence limits overlap
and show that 31% of women aged 50–64 reported
symptoms associated with a major depressive episode.
Current symptom severity for respondents reporting
lifetime major depression symptoms was moderate or
greater in 4.9% of respondents while 75.6% of partici-
pants reported no current symptoms of depression
(Table 8).Discussion
To our knowledge, this is one of the first large-scale
implementations of PhenX Toolkit measures since their
release. The use of standardized tools is vital to discov-
ery efforts in the field of medical genomics. We quickly
discovered in the eMERGE network that larger sample
sizes than were originally anticipated were needed for
straight GWAS analyses, in part because of different
technologies and phenotype definitions used across the
network [3]. Gene/environment analyses are further
compromised when standardized tools are not used be-
cause data cannot be reliably merged across studies to
allow for necessary validation or increased sample sizes
for meta analyses that yield statistically significant results.
Use and incorporation of PhenX data into dbGaP along
with GWAS data will facilitate large-scale gene/environ-
ment studies and we support these efforts. The PhenX
data have been submitted to dbGaP (dbGaP study acces-
sion: phs000170.v1.p1) for the current study to be merged
with other phenotypic data and GWAS genotypes already
available in dbGaP to the research community. The dbGaPTable 7 Age and sex-specific distribution of PhenX WHO CIDI
published data
Male
Study Age 50-64 Age 65+
MDE% (9.5% CL) MDE% (95% C
PhenX 14.2 (9.5, 18.8) 8.8 (6.7, 11.0)
NCR-R* 16.2 (13.5, 18.9) 5.3 (2.9, 7.7)
*National Comorbidity Surveys Replication, Kessler et al. 2010 [8].website contains information about how to access data
(www.ncbi.nlm.nih.gov/gap).
Many of the items that we selected from the Toolkit
were intended for interviewer-administration. We selected
items based on content, not mode of administration and
had to remove interviewer instructions prior to adminis-
tration. With feedback from the PhenX RISING network,
the Toolkit has been amended to allow researchers to se-
lect a self-administered option. After completion of for-
matting to allow self-administration, we found the PhenX
Toolkit easy to use with minimal queries from participants
about how to complete the forms. Most questions were
related to the Family Health History section for heart
attack or myocardial infarction because of difficulty in
understanding the table format. Some people needed
clarification related to the type of dwelling they lived in
fitting their home into one of the category options
listed. A few queries were related to depression, stroke
follow-up questions and sun exposure. The data are be-
ing mapped in dbGaP to the PhenX Toolkit measures to
allow other researchers to combine PhenX data across
studies to increase statistical power for gene/environment
studies.
Observed differences between the PhenX and PMRP
were expected for some variables, such as age, because
of the time difference between enrollment into PMRP
and completion of the PhenX questionnaire. The lower
mean weight and concomitant BMI in PhenX would not
be expected because average weight generally increases as
a population ages. However, the mode of data collection
was different. At the time of enrollment into PMRP, par-
ticipants had standardized measurements of height and
weight from which BMI was calculated [4]. For PhenX,
weight and height were self-reported. A systematic review
of studies comparing self-reported and measured height
and weight found a trend of under-reporting of weight
and over-reporting of height which was inconsistent [10],
and which would explain the lower mean weight observed
in the PhenX questionnaire when compared with the
direct measurement at enrollment into PMRP. Specific
instructions within the PhenX Toolkit warn researchers
that “Self-reported weight values are considered to be
less accurate. Self-reported weight is subject to error
and is used when measured weight cannot be obtained”.-SF major depression episode (MDE) and comparison with
Female
Age 50-64 Age 65+
L) MDE% (95% CL) MDE% (95% CL)
31.3 (26.6, 36.1) 11.9 (9.8, 14.0)
24.6 (21.7, 27.5) 13.0 (10.5. 15.5)
Table 8 QIDS-SR depression symptom severity reported
on the PhenX survey
None Mild Moderate Severe Very severe
N (%) N (%) N (%) N (%) N (%)
1582 (75.6) 409 (19.5) 87 (4.2) 12 (0.6) 3 (0.1)
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report, it is not possible to create rules to adjust self-
reported weight or to assume the relative position of
weight in a population is constant. Our data support the
PhenX Toolkit cautionary note to only use self-reported
weight when it is not possible to obtain a measured
weight.
There was a large difference in self-reported family
history of heart attack between the two questionnaires
in the current study (52.8% versus 28.1%) and there are
several potential reasons for this difference. First, the
time difference between administration of the two
questionnaires provided more opportunity for first de-
gree relatives to experience a heart attack by the time
of the PhenX questionnaire and in fact the rate was
higher in that survey. Second, the questions were not
asked identically. The PMRP question included both
angina and heart attack. Accuracy of self-reported fam-
ily history has been shown to vary by personal health
history [11].
The positive predictive value of self-reported physician-
diagnosed stroke was found to be lower than the negative
predictive-value in the present study (81.4% versus 98.1%).
A study conducted in Olmstead County, Minnesota
revealed positive and negative predictive values for
stroke including TIA of 67.4% and 99.2% respectively,
with higher levels of agreement observed in older
ages, women, and more educated individuals [12]. In
addition to the difference in disease definition, mode
of administration may have led to observed differ-
ences. The PhenX stroke protocol was intended to be
interviewer-administered and was self-administered in
the current study and the gold standard for the
current study was physician assessment. Consideration
should be given to being more specific with the PhenX
question so that respondents understand the difference
between TIA and stroke because they are not identical
terms.
Data for direct validation of the major depressive
episode (MDE) PhenX questions were not available
but a comparison of the rates documented in PMRP
with the PhenX Toolkit revealed markedly similar
MDE rates with previously published age- and gender-
specific rates from the WHO World Mental Health
Survey Initiative [8,9]. This lends external validity to
the results.Conclusions
In conclusion, we demonstrated the ease and utility of
the PhenX Toolkit to quantify exposures that can be
used to facilitate gene/environment analyses. Future
studies will leverage available GWAS data for this cohort
of participants.
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